Vault-13

DIANTHUS THERAPEUTICS INC DNTH

COM · Common Stock · CUSIP 252828108

Biotechnology company

31 institutional holders
10,072,64410.1m shares reported held*
68.0% of all shares outstanding*
$136.3mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 14.8m as of 2023-11-09, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $13.53. Options: 2 managers hold calls ($3.8k notional), 1 hold puts ($0).

Trends to Q3 2023

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$1k$2k$3k$4kQ4 22 calls: $0Q4 22 puts: $0Q4 22P/C —Q1 23 calls: $0Q1 23 puts: $0Q1 23P/C —Q2 23 calls: $0Q2 23 puts: $0Q2 23P/C —Q3 23 calls: $3.8kQ3 23 puts: $0Q3 23P/C 0.00
Numbers
QuarterCallsPutsP/C
Q4 2022$0$0—
Q1 2023$0$0—
Q2 2023$0$0—
Q3 2023$3.8k$00.00

Biggest buyers

FMR LLC New +2,218,212+2.2m
Fairmount Funds Management LLC New +1,928,503+1.9m
5AM Venture Management, LLC New +1,472,264+1.5m
Avidity Partners Management LP New +1,217,554+1.2m
Venrock Adviser, LLC New +927,706+927.7k
TANG CAPITAL MANAGEMENT LLC New +591,636+591.6k
Octagon Capital Advisors LP New +480,000+480.0k
Nantahala Capital Management, LLC New +336,862+336.9k
Atlas Venture Life Science Advisors, LLC New +236,979+237.0k
Alphabet Inc. New +208,697+208.7k

Biggest sellers

None

Biggest calls

Biggest puts

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
FMR LLC 13G · institution +1.0 pts · filed 2025-11-05 15.0% +1.0 pts 6.0m≈ $582.0m 2025-11-05
T. Rowe Price Investment Management, Inc. 13G · institution +5.0 pts · filed 2026-08-07 12.1% +5.0 pts 6.6m≈ $646.5m 2026-08-07
BlackRock, Inc. 13G · institution +1.3 pts · filed 2026-07-28 6.4% +1.3 pts 3.5m≈ $341.6m 2026-07-28
WELLINGTON MANAGEMENT GROUP LLP 13G · institution +1.1 pts · filed 2026-08-13 5.9% +1.1 pts 3.2m≈ $314.8m 2026-08-13

Fell to 5% or below in the last year: Sirenia Capital Management LP (3.1%, 2026-08-14), RA CAPITAL MANAGEMENT, L.P. (4.8%, 2026-05-15), Point72 Asset Management, L.P. (1.2%, 2026-05-15), Octagon Capital Advisors LP (3.6%, 2026-05-14), Fairmount Funds Management LLC (4.9%, 2025-11-25)

Insider purchases and sales in Q3 2023

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
202Q4 21: 0 buyingQ4 21: 0 sellingQ1 22: 0 buyingQ1 22: 0 sellingQ1 22Q2 22: 0 buyingQ2 22: 0 sellingQ3 22: 0 buyingQ3 22: 0 sellingQ3 22Q4 22: 0 buyingQ4 22: 0 sellingQ1 23: 0 buyingQ1 23: 0 sellingQ1 23Q2 23: 0 buyingQ2 23: 0 sellingQ3 23: 2 buyingQ3 23: 0 sellingQ3 23
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20210—0——
Q1 20220—0——
Q2 20220—0——
Q3 20220—0——
Q4 20220—0——
Q1 20230—0——
Q2 20230—0——
Q3 20232$1.5m0——
DateInsiderTradeSharesPrice ValueTheir holding
2023-09-29 Harwin Peter Evan +2 Director · See footnote Bought 24,670 $13.63 $336.3k24.7k shares +1%
2023-09-26 Harwin Peter Evan +2 Director · See footnote Bought 30,000 $13.15 $394.5k30.0k shares +2%
2023-09-22 Randhawa Simrat Chief Medical Officer Bought 2,000 $13.20 $26.4k2.0k shares +100%
2023-09-21 Randhawa Simrat Chief Medical Officer Bought 2,000 $13.20 $26.4k2.0k shares new
2023-09-19 Harwin Peter Evan +2 Director · See footnote Bought 30,000 $13.20 $396.0k30.0k shares +2%
2023-09-13 Harwin Peter Evan +2 Director · See footnote Bought 9,367 $11.76 $110.2k9.4k shares +0%
2023-09-12 Harwin Peter Evan +2 Director · See footnote Bought 14,887 $10.85 $161.5k14.9k shares +1%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q3 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 FMR LLC 0.00% of their portfolio BOSTON, MA 2,218,2122.2m $29.0m $29.0m 0.00% New
2 Fairmount Funds Management LLC 3.17% of their portfolio WEST CONSHOHOCKEN, PA 1,928,5031.9m $26.4m $26.4m 3.17% New
3 5AM Venture Management, LLC 5.79% of their portfolio SAN FRANCISCO, CA 1,472,2641.5m $20.1m $20.1m 5.79% New
4 Avidity Partners Management LP 0.67% of their portfolio DALLAS, TX 1,217,5541.2m $16.6m $16.6m 0.67% New
5 Venrock Adviser, LLC 1.33% of their portfolio NEW YORK, NY 927,706927.7k $12.7m $12.7m 1.33% New
6 TANG CAPITAL MANAGEMENT LLC 1.14% of their portfolio SAN DIEGO, CA 591,636591.6k $8.1m $8.1m 1.14% New
7 Octagon Capital Advisors LP 1.16% of their portfolio NEW YORK, NY 480,000480.0k $6.6m $6.6m 1.16% New
8 Nantahala Capital Management, LLC 0.58% of their portfolio NEW CANAAN, CT 336,862336.9k $4.6m $4.6m 0.58% New
9 Atlas Venture Life Science Advisors, LLC 0.50% of their portfolio CAMBRIDGE, MA 236,979237.0k $3.2m $3.2m 0.50% New
10 Alphabet Inc. 0.18% of their portfolio Mountain View, CA 208,697208.7k $2.9m $2.9m 0.18% New
11 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 126,877126.9k $1.7m $1.7m 0.00% New
12 CITADEL ADVISORS LLC 0.00% of their portfolio MIAMI, FL 105,561105.6k $1.4m $1.4m 0.00% New
13 Laurion Capital Management LP 0.01% of their portfolio NEW YORK, NY 36,39336.4k $497.5k $497.5k 0.01% New
14 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 35,21635.2k $481.0k $481.0k 0.00% New
15 BlackRock Inc. 0.00% of their portfolio New York, NY 32,15132.2k $439.5k $439.5k 0.00% New
16 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 26,34126.3k $360.2k $360.2k 0.00% New
17 ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio Boston, MA 22,29922.3k $303.0k $303.0k 0.00% New
18 ArrowMark Colorado Holdings LLC 0.00% of their portfolio Denver, CO 20,78820.8k $284.2k $284.2k 0.00% New
19 RBF Capital, LLC 0.01% of their portfolio RENO, NV 15,67615.7k $214.3k $214.3k 0.01% New
20 BESSEMER GROUP INC 0.00% of their portfolio WOODBRIDGE, NJ 14,82914.8k $203.0k $203.0k 0.00% New
21 Jefferies Financial Group Inc. 0.00% of their portfolio NEW YORK, NY 13,20013.2k $180.4k $180.4k 0.00% New
22 CITIGROUP INC 0.00% of their portfolio NEW YORK, NY 3,8683.9k $52.9k $52.9k 0.00% New
23 ROYAL BANK OF CANADA 0.00% of their portfolio TORONTO, A6 339339 $4.0k $4.0k 0.00% New
24 UBS Group AG 0.00% of their portfolio ZURICH, V8 319319 $4.4k $4.4k 0.00% New
25 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 155155 $2.1k $2.1k 0.00% New
26 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 122122 $1.7k $1.7k 0.00% New
27 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 5050 $684 $684 0.00% New
28 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 4141 $560 $560 0.00% New
29 INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 0.00% of their portfolio Fort Collins, CO 33 $41 $41 0.00% New
30 Qube Research & Technologies Ltd 0.00% of their portfolio LONDON, X0 33 $41 $41 0.00% New
31 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% New